Print version Decrease text Increase text

MEPHITIS

Targetting protein synthesis in the apicoplast and cytoplasm of plasmodium
 
 
Framework programme:
 7
Contract/Grant agreement number:
223024
EC contribution:
2.100.000 €
Duration:
36 months
Funding scheme:
Small-Medium Collaborative Project (SICA)
Starting date:
01/01/2009
 
 

Keywords: malaria, Plasmodium falciparum, drug development, protein synthesis, drug screening, apicoplast, tRNA, aminoacyl-tRNA synthetases, elongation factors

Background

The protein synthesis machinery represents one of the most useful targets for the development of new anti-infectives. Several families of broadly used antibiotics (tetracyclines, macrolides, and novel glycopeptides like vancomycin, among others) exert their function by blocking the protein synthesis machinery. Doxycycline, a tetracycline antibiotic, remains a useful tool for the prevention of paludism among travellers, despite its numerous secondary effects. But very little is known about the specifics of the protein synthesis machinery in Plasmodium.

Lack of information about this central metabolic pathway in Plasmodium clearly blocks the possibility of transferring the knowledge in protein synthesis to the development of new antimalarial drugs directed against the translational machinery of the parasite. Thus, the study of components of the genetic code in Plasmodium has the potential for providing new and important information on the biology of the parasite and, more importantly, open new leads for the development of novel antimalarials.

Aims and expected results

  • MEPHITIS has started to generate its first results towards a better understanding of protein synthesis and the discovery of new protein synthesis inhibitors with anti-malarial activity.
  • A large battery of known molecular inhibitors previously uncharacterised in Plasmodium cultures has been tested, and two drugs with powerful inhibitory activity have been identified. Currently these molecules are being tested alone and in combination in animal models of Plasmodium infection to determine their real potential as anti-malarial therapeutics.
  • An ambitious effort has also been initiated to obtain crystal structures of crucial components of the protein synthesis apparatus. A broad collaboration within Mephitis is providing crystallography groups in India and Europe with the necessary material to carry out this goal.
  • Finally, new and uncharacterised aspects of protein synthesis in Plasmodium are being studied, with a particular emphasis in the analysis of protein synthesis in the apicoplast and in relation to the host’s genetic apparatus.

Coordinator:

Prof. Lluis Ribas de Poulana
IRB Barcelona
Barcelona
Spain
E-mail: lluis.ribas@irbbarcelona.org

Partners:

Principal
Scientific
Participants
Official Address Other Information
1 Dr Amit Sharma International Centre for Genetic Engineering and
Biotechnology (ICGEB)
New Delhi
India
Email:
amit.icgeb@gmail.com
2 Dr Magali Frugier Centre National de la Recherche Scientifique
IBMC René Descartes
Strasbourg
France
Email:
M.Frugier@ibmc.u-strasbg.fr
3 Prof. Manuel Antonio da Silva Santos Universidade de Aveiro
University of Aveiro
Aveiro
Portugal
Email:
msantos@bio.ua.pt
4 Dr Miriam Royo Exposito Fundacio Privada Parc Cientific de Barcelona
Barcelona
Spain
Email:
mroyo@pcb.ub.es
5 Dr Stuart Ralph University of Melbourne
Melbourne
Australia
Email: saralph@unimelb.edu.au
6 Dr Elisabetta Pizzi Istituto Superiore di Sanita
Rome
Italy
Email:
elisabetta.pizzi@iss.it
7 Dr Saman Habib Council of Scientific and Industrial Research
Lucknow
India
Email:
saman.habib@gmail.com
top